Everolimus in advanced/metastatic renal cell carcinoma in adults after sunitinib progression

被引：0
|
作者：
Martin-Vila, A. [1 ]
Alvarez-Payero, M. [1 ]
Martinez-Lopez de Castro, N. [1 ]
Suarez-Santamaria, M. [1 ]
Castro-Dominguez, J. M. [1 ]
Ascunce-Saldana, M. D. P. [1 ]
机构：
[1] Hosp Meixoeiro, Complexo Hosp Univ Vigo, Vigo, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2013年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：907 / 907
页数：1
相关论文
共 50 条
  • [41] Re: Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma
    Flanigan, Robert C.
    EUROPEAN UROLOGY, 2019, 75 (05) : 876 - 877
  • [42] Everolimus for the treatment of advanced renal cell carcinoma
    Amato, Robert
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (07) : 1143 - 1155
  • [43] Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale
    Grunwald, Viktor
    Powles, Thomas
    Choueiri, Toni K.
    Hutson, Thomas E.
    Porta, Camillo
    Eto, Masatoshi
    Sternberg, Cora N.
    Rha, Sun Young
    He, Cixin S.
    Dutcus, Corina E.
    Smith, Alan
    Dutta, Lea
    Mody, Kalgi
    Motzer, Robert J.
    FUTURE ONCOLOGY, 2019, 15 (09) : 929 - 941
  • [44] Comparing Everolimus to Sunitinib in Non-clear-cell Renal Cell Carcinoma
    Bex, Axel
    Ljungberg, Borje
    EUROPEAN UROLOGY, 2016, 69 (05) : 875 - 876
  • [45] Sunitinib versus everolimus for non-clear-cell renal cell carcinoma
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (3) : 124 - 124
  • [46] Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma
    Nachbargauer, Sebastian
    Bruchbacher, Andreas
    Fajkovic, Harun
    Remzi, Mesut
    Schmidinger, Manuela
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : E277 - E283
  • [47] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Bajic, Petar
    Flanigan, Robert C.
    Joyce, Cara J.
    Clark, Joseph I.
    JOURNAL OF UROLOGY, 2019, 201 (03): : 453 - 454
  • [48] Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy
    Barragan-Carrillo, Regina
    Govindarajan, Ameish
    Rock, Adam
    Sperandio, Rubens C.
    Pal, Sumanta K.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (05) : 965 - 976
  • [49] SUNITINIB RECHALLANGE IN METASTATIC RENAL CELL CARCINOMA PATIENTS
    Nagyivanyi, K.
    Biro, K.
    Gyergyay, F.
    Kueronya, Z.
    Nemeth, H.
    Geczi, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 281 - 281
  • [50] Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis
    Yoon, Sang Hyun
    Kim, Ki Hyang
    Choi, Junjeong
    Kim, Gun Min
    Kim, Joo Hoon
    Kim, Hyo Song
    Park, Young Nyun
    Rha, Sun Young
    CANCER RESEARCH AND TREATMENT, 2010, 42 (03): : 180 - 184
12345